ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P ASX 200
7,968.20
0.60%
S&P ASX All Technology
3,399.00
0.55%
Brent Oil
65.585
-0.28%
US Dollar vs AUD
1.5673
0.31%
Bitcoin
93,835.60
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Mgc Pharmaceuticals Limited (MXC) Share Price

Mgc Pharmaceuticals Limited

Mgc Pharmaceuticals Limited (MXC)

Mexco Energy Corp
MGC Pharmaceuticals Ltd
22.00
0.00
( 0.00% )
Updated: 10:00:00
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
22.00
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
22.00 52 Week Range 22.00
Market Cap
9.647M
Previous Close
22.00
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
43,851,631
Dividend Yield
-
PE Ratio
-0.38
Earnings Per Share (EPS)
-0.4
Revenue
3.02M
Net Profit
-17.53M

About Mgc Pharmaceuticals Limited

Sector
Drug & Proprietary Stores
Industry
Drug & Proprietary Stores
Website
www.mgcpharma.com.au
Headquarters
Perth, Western Australia, Aus
Founded
-
Mgc Pharmaceuticals Limited is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker MXC. The last closing price for Mgc Pharmaceuticals was 22p. Over the last year, Mgc Pharmaceuticals shares have traded in a share price range of 22.00p to 22.00p.

Mgc Pharmaceuticals currently has 43,851,631 shares in issue. The market capitalisation of Mgc Pharmaceuticals is £9.65 million. Mgc Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.38.

Ask ADVFN Intelligence (AI)

MXC Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10022222200DE
40022222200DE
120022222200DE
260022222200DE
520022222200DE
156-172711.019922-99.9872635817172733.019922218560.14765615222230368785.7734826DE
260-296091.748437-99.9925704226296113.7484371307835.72227155460718402105.241389DE

MXC - Frequently Asked Questions (FAQ)

What is the current Mgc Pharmaceuticals share price?
The current share price of Mgc Pharmaceuticals is 22.00p
How many Mgc Pharmaceuticals shares are in issue?
Mgc Pharmaceuticals has 43,851,631 shares in issue
What is the market cap of Mgc Pharmaceuticals?
The market capitalisation of Mgc Pharmaceuticals is GBP 9.65M
What is the 1 year trading range for Mgc Pharmaceuticals share price?
Mgc Pharmaceuticals has traded in the range of 22.00p to 22.00p during the past year
What is the PE ratio of Mgc Pharmaceuticals?
The price to earnings ratio of Mgc Pharmaceuticals is -0.38
What is the cash to sales ratio of Mgc Pharmaceuticals?
The cash to sales ratio of Mgc Pharmaceuticals is 2.18
What is the reporting currency for Mgc Pharmaceuticals?
Mgc Pharmaceuticals reports financial results in AUD
What is the latest annual turnover for Mgc Pharmaceuticals?
The latest annual turnover of Mgc Pharmaceuticals is AUD 3.02M
What is the latest annual profit for Mgc Pharmaceuticals?
The latest annual profit of Mgc Pharmaceuticals is AUD -17.53M
What is the registered address of Mgc Pharmaceuticals?
The registered address for Mgc Pharmaceuticals is 1202 HAY STREET, PERTH, WESTERN AUSTRALIA, 6005
What is the Mgc Pharmaceuticals website address?
The website address for Mgc Pharmaceuticals is www.mgcpharma.com.au
Which industry sector does Mgc Pharmaceuticals operate in?
Mgc Pharmaceuticals operates in the DRUG & PROPRIETARY STORES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSFABsf Enterprise Plc
3.625p
(163.64%)
9.54M
SYMESupply@me Capital Plc
0.005p
(42.86%)
67.53M
CHFChesterfield Resources Plc
0.80p
(36.75%)
1.53M
EMEEmpyrean Energy Plc
0.12p
(23.08%)
97.09M
MET1Metals One Plc
19.00p
(22.58%)
2.04M
NTQEnteq Technologies Plc
0.55p
(-64.52%)
3.49M
MCGMobico Group Plc
42.50p
(-27.91%)
7.72M
CODENorthcoders Group Plc
69.50p
(-27.60%)
109.08k
CTAICatenai Plc
0.415p
(-20.95%)
51.4M
PRMProteome Sciences Plc
2.52p
(-20.00%)
37.18k
CHPCaledonian Holdings Plc
0.0045p
(0.00%)
1.77B
PREMPremier African Minerals Limited
0.0385p
(-9.41%)
1.72B
VASTVast Resources Plc
0.45p
(1.12%)
409.2M
TRPTower Resources Plc
0.026p
(-5.45%)
271.72M
SNDASunda Energy Plc
0.065p
(-10.34%)
165.17M

Discussion

View Full Feed
BIOCHEMUP BIOCHEMUP 5 minutes ago
I'm in. 
AREB
floridaboy floridaboy 5 minutes ago
May 5th is projected separation date...
SAPX
sab63090 sab63090 5 minutes ago
Fridays are sometimes good days for $AVXL so maybe we "get lucky" and see that $10 to $10.50 resistance taken out!

Daily:

https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=avxl&time=8&startdate=1%2F4%2F1999&enddate=4%2F11%2F2025&fre
AVXL
SkeBallLarry SkeBallLarry 6 minutes ago
UpDate from DOGE >

Latest work
Follow on
DOGE
Department of Government Efficiency
@DOGE
Great work by @SecNav @USNavy
canceling wasteful grants, such as the "population consequences of the disturbance of
humpback whales in the context
wannabeeriche wannabeeriche 6 minutes ago
BNGO – The Future in Leukemia Research

OGM offers a holistic and unbiased approach to genomic analysis, detecting large structural variants that traditional methods often fail to identify.

Leukemia research demands a modern and comprehensive genomic standard, and Optic
BNGO
wannabeeriche wannabeeriche 6 minutes ago
BNGO – The Future in Leukemia Research

OGM offers a holistic and unbiased approach to genomic analysis, detecting large structural variants that traditional methods often fail to identify.

Leukemia research demands a modern and comprehensive genomic standard, and Optic
BNGO
floridaboy floridaboy 8 minutes ago
Simple... Reduced AS and OS, interest will return
DRGV
floridaboy floridaboy 8 minutes ago
Looks like towel not being thrown in yet ..
DRGV
sctts sctts 9 minutes ago
$$$ Today is the Day $$$$

$$$$ $FRX $$$
FRX
Ronnie Replay Ronnie Replay 11 minutes ago
Please enlighten me on how a company and the shareholders in EM would benefit from receiving such information. Except to appease people who complain nonstop such as yourself. If you had any intelligence you would know divulging information such as how many partners and who they are or how many subsc
CNNA
rmmc rmmc 13 minutes ago
HIRU is that far under your skin you cannot even talk reality about what it has done in the past and will do. You talk like every investor on this board is a child and you are the only voice that can save them, are you that far gone? I guess so. Hope your family can save you from the dark place your
HIRU
tractor4sale tractor4sale 13 minutes ago
You were asked for the link to prove your statement that Dixon got crucified in court and as usual, nothing is provided for validation purposes! Wishful thinking as usual but nobody is surprised!
TSOI
sab63090 sab63090 13 minutes ago
I always have trouble with people who dispute what you have posted with a quick reply of "not correct" and don't elaborate...they might be right or wrong and never bring in a sensible response....you have at least given your reasons.👍️
AVXL
capgain capgain 17 minutes ago
GM Ks, and all. The criminals are so used to getting a pass, not anymore.
BIOCHEMUP BIOCHEMUP 17 minutes ago
I need to get back in lol 
AREB
north40000 north40000 17 minutes ago
Monk, that buyout at $300-400/share could happen. Look at Dew Diligence posts on Biotech Value board. He keeps a record or table of all BOs that are public. Premiums paid by buyers are often 2 to 6 to 10 times market price at time of BO. E.g.,, $50---> $300. How many shares does AMRN have today afte
AMRN
sam1933 sam1933 18 minutes ago
$HBAR weekly chart, suggesting that a new ATH may be within reach in the near future.
https://schrts.co/vZQnPFUY
HBAR
capgain capgain 19 minutes ago
Waymore's Blues

https://www.youtube.com/watch?v=BLtmkEPo0Pc
INV4 INV4 20 minutes ago
Yes, I now save it daily (if it's updated). So you can all see how much the OS has increased over the past few days/weeks. There's no other way to see this (the previous OS's etc per day), not as far as I know.

You can check this here: https://www.otcmarkets.com/stock/EMED/security
EMED
Edward Edward 21 minutes ago
Fits VXIT to a tee:

Investors sometimes target micro-cap stocks for "pump and dump" schemes, where they talk up a given micro-cap stock and wait for others to pump up the stock price. After gains are priced in, they quickly dump their shares and harvest profits and the stock quickly
VXIT
INV4 INV4 23 minutes ago
Market Cap | 517,151 | 04/24/2025
Authorized Shares | 5,000,000,000 | 04/24/2025
Outstanding Shares | 2,585,755,492 | 04/24/2025
Restricted | 134,567,800 | 04/24/2025
Unrestricted | 2,451,187,692 | 04/24/2025
Held at DTC | 2,443,619,211 | 04/24/2025
Float |
EMED
StayHumble StayHumble 25 minutes ago
wow💹 Verified LOTS of SHORTS Here✅Squeeze Incoming 💹✅💹 wow
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
HMBL
ksquared ksquared 25 minutes ago
Federal prosecutors officially file intent to seek death penalty against Luigi Mangione
By Andrea Margolis, Fox News Published April 25, 2025, 3:30 a.m. ET
(With any luck his twisted fan base will commit mass suicide in solidarity with his execution.)

Federal prosecut
vuletini vuletini 29 minutes ago
Hope is not a strategy old galoot
SHIBUSD

Your Recent History

LSE
MXC
Mgc Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads